Select Publications
Journal articles
2009, 'A practical guide on PSA testing', Medicine Today, 10, pp. 57 - 61
,2009, 'Treatment options for localised prostate cancer', Medicine Today, 10, pp. 63 - 66
,2009, 'Gene-based prediction of PSA recurrence for clinically localized prostate cancer patients', Journal of Clinical Oncology, 27, pp. 5132 - 5132, http://dx.doi.org/10.1200/jco.2009.27.15_suppl.5132
,2009, 'THE CLINICO-PATHOLOGICAL OUTCOME OF MEN UNDERGOING PROSTATECTOMY WITH PSA <= 4', JOURNAL OF UROLOGY, 181, pp. 777 - 777, http://dx.doi.org/10.1016/S0022-5347(09)62163-7
,, 2009, 'Abstracts of the Urological Society of Australia and New Zealand 62nd Annual Scientific Meeting. March 8-12, 2009. Gold Coast, Australia.', BJU Int, 103 Suppl 1, pp. 1 - 48, http://dx.doi.org/10.1111/j.1464-410X.2009.09021.x
2009, 'MP-05.16: Should Experienced Open Prostatic Surgeons Convert to Robotic Surgery? The Real Learning Curve for a Single Surgeon', Urology, 74, pp. S67 - S68, http://dx.doi.org/10.1016/j.urology.2009.07.1019
,2009, 'MP-16.07: Comparative Analysis between Robotic Assisted Laparoscopic Prostatectomy and Open Radical Prostatectomy: Defining the Initial Learning Curve', Urology, 74, pp. S121 - S121, http://dx.doi.org/10.1016/j.urology.2009.07.821
,2009, 'MP-16.19: High Dose Rate Brachytherapy Compared to Open Radical Prostatectomy for the Treatment of High-Risk Prostate Cancer: 10 Year Biochemical Relapse-Free Survival', Urology, 74, pp. S125 - S125, http://dx.doi.org/10.1016/j.urology.2009.07.1317
,2009, 'Quality of life three years after diagnosis of localised prostate cancer: population based cohort study', British Medical Journal, 339, pp. 1 - 12
,2009, 'UP-1.129: The Clinico-Pathological Outcome of Men Undergoing Prostatectomy with PSA ≤ 4', Urology, 74, pp. S211 - S211, http://dx.doi.org/10.1016/j.urology.2009.07.576
,2009, 'UP-2.133: Biochemical Relapse-Free Survival and Quality of Life Analysis in Localised Prostate Cancer Following Low Dose I125 Brachytherapy', Urology, 74, pp. S272 - S273, http://dx.doi.org/10.1016/j.urology.2009.07.352
,2008, 'Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy', INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 20, pp. 479 - 486, http://dx.doi.org/10.1038/ijir.2008.33
,2008, 'Stage migration and the Kattan nomogram', JOURNAL OF CLINICAL ONCOLOGY, 26, http://dx.doi.org/10.1200/jco.2008.26.15_suppl.5162
,2008, 'ANALYSIS OF THE EPSTEIN CRITERIA FOR INSIGNIFICANT PROSTATE CANCER IN AUSTRALIAN MEN', Journal of Urology, 179, pp. 687 - 687, http://dx.doi.org/10.1016/s0022-5347(08)62006-6
,2008, 'Androgen regulation of multidrug resistance-associated protein 4 (MRP4/ABCC4) in prostate cancer', Prostate, 68, pp. 1421 - 1429
,2008, 'Immunohistochemical level of unsulfated chondroitin disaccharides in the cancer stroma is an independent predictor of prostate cancer relapse', Cancer epidemiology biomarkers and prevention, 17, pp. 2488 - 2497
,2008, 'MP-4.06: Do the Epstein Criteria Continue to Predict Insignificant Prostate Cancer in the Modern Day Urological Setting?', Urology, 72, pp. S85 - S85, http://dx.doi.org/10.1016/j.urology.2008.08.248
,2008, 'Quality of life outcomes in patients undergoing emerging techniques for the treatment of localised prostate cancer: a prospective study', British Journal of Urology, 101, pp. 35 - 35
,2008, 'UP.59: Quality-Of-Life Outcomes in Patients Undergoing Emerging Techniques for the Treatment of Localised Prostate Cancer: A Prospective Study', Urology, 72, pp. S128 - S128, http://dx.doi.org/10.1016/j.urology.2008.08.381
,2008, 'UP.60: Issues Faced in the Transition From Open to Robot-Assisted Laparoscopic Radical Prostatectomy in the Contemporary Era', Urology, 72, pp. S128 - S128, http://dx.doi.org/10.1016/j.urology.2008.08.382
,2007, 'Saw palmetto and lower urinary tract symptoms in men', Medicine Today, 8, pp. 71 - 72
,2007, '1130: PTEN Expression in Premalignant Prostate Disease', Journal of Urology, 177, pp. 373 - 373, http://dx.doi.org/10.1016/s0022-5347(18)31344-2
,2007, 'Magnetic resonance imaging in the diagnosis and localisation of prostate cancer: a comparison of biopsy and radical prostatectomy specimens with endorectal MRI', British Journal of Urology, 99, pp. 4 - 5
,2007, 'MP-11.18: Is there evidence of a continued stage migration in the PSA screening era in an Australian population?', Urology, 70, pp. 99 - 100, http://dx.doi.org/10.1016/j.urology.2007.06.401
,2006, 'Zinc-alpha2-glycoprotein expression as a predictor of metastatic prostate cancer following radical prostatectomy', Journal of the National Cancer Institute, 98, pp. 1420 - 1424, http://dx.doi.org/10.1093/jnci/djj378
,2006, 'Elevated multidrug resistance-associated protein 4 (MRP4) expression in localized prostate cancer—A potential androgen regulated protein', Journal of Clinical Oncology, 24, pp. 20022 - 20022, http://dx.doi.org/10.1200/jco.2006.24.18_suppl.20022
,2006, '12 Outcomes of radical prostatectomies and HDR brachytherapy in patients with intermediate and high risk prostate cancer', BJU International, 97, pp. 3 - 3, http://dx.doi.org/10.1111/j.1464-410x.2006.06085_12.x
,2006, '13 Treatment of localised prostate cancer using a combination of high dose‐rate Ir‐192 brachytherapy (HDRB) and external beam radiation therapy (EBRT): a 7 year experience', BJU International, 97, pp. 3 - 4, http://dx.doi.org/10.1111/j.1464-410x.2006.06085_13.x
,2006, 'Aberrant neuropepticle Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis', Cancer epidemiology biomarkers and prevention, 15, pp. 711 - 716
,2005, 'Assessing and managing benign prostatic hyperpasia', Medicine Today, 6, pp. 12 - 20
,2005, '1022 Prediction of adverse radical prostatectomy pathology in patients with single positive biopsy Gleason 6 prostate cancer', European Urology Supplements, 4, pp. 258 - 258, http://dx.doi.org/10.1016/s1569-9056(05)81026-7
,2005, 'Cross-sectional analysis of sexual function after prostate brachytherapy', Urology, 66, pp. 377 - 381
,2005, 'Lower levels of nuclear b-catenin predict for a poorer prognosis in localised prostate cancer', International Journal of Cancer, 113, pp. 415 - 422
,2005, 'Prognostic impact of positive surgical margins in surgically treated prostate cancer: Multi-institutional assessment of 5831 patients', Urology, 66, pp. 1245 - 1250
,2005, 'The propeptide mediates formation of stromal stores of ProMIC-1: role in determining prostate cancer outcome', Cancer Research, 65, pp. 2330 - 2336, http://dx.doi.org/10.1158/0008-5472.CAN-04-3827
,2004, 'Localised prostate cancer questions patients ask', Medicine Today, 5, pp. 18 - 31
,2004, 'Nuclear beta-catenin as a marker of outcome in localized prostate cancer', Journal of Clinical Oncology, 22, pp. 9570 - 9570, http://dx.doi.org/10.1200/jco.2004.22.90140.9570
,2004, 'Nuclear beta-catenin as a marker of outcome in localized prostate cancer', Journal of Clinical Oncology, 22, pp. 9570 - 9570, http://dx.doi.org/10.1200/jco.2004.22.14_suppl.9570
,2004, 'Prostate cancer screening (multiple letters)', Medicine Today, 5, pp. 13
,2004, '1079: Neuropeptide Y Expression is increased in the Progression from Benign to Malignant Prostate Epithelium and Predicts Outcome after Radical Prostatectomy', Journal of Urology, 171, pp. 284 - 285, http://dx.doi.org/10.1016/s0022-5347(18)38316-2
,2004, '173 Solitary positive apical margin a treatment dilemma', European Urology Supplements, 3, pp. 46 - 46, http://dx.doi.org/10.1016/s1569-9056(04)90174-1
,2004, 'Is year of radical prostatectomy a predictor of outcome in prostatecancer?', Journal of Urology, 171, pp. 692 - 696
,2004, 'Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression', Prostate, 59, pp. 234 - 242, http://www.sciencedirect.com/science/article/B6WVB-4C7SGSS-309/2/7b9a758bff091ff595430f8afc3931fd
,2004, 'Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitro', Clinical Cancer Research, 10, pp. 615 - 625, http://www.sciencedirect.com/science/article/B6WVB-4C6K0YK-1KG/2/9870ea381b7532fc0a83fed7069d24d3
,2004, 'Nuclear beta-catenin as a marker of outcome in localized prostate cancer', Journal of Clinical Oncology, 22, pp. 852S - 852S
,2004, 'Preclinical validation of anti-TMEFF2-auristatin E-conjugatedantibodies in the treatment of prostate cancer', Molecular Cancer Therapeutics, 3, pp. 921 - 932
,2003, 'Treatment of localized prostate cancer using a combination of high dose rate Iridium-192 brachytherapy and external beam irradiation: Initial Australian experience', Australasian Radiology, 47, pp. 152 - 160, http://dx.doi.org/10.1046/j.0004-8461.2003.01143.x
,2003, 'A pre-operative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer', Journal of Urology, 170, pp. 1798 - 1803
,2003, 'Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease ot invasive prostate cancer', Oncogene, 22, pp. 6005 - 6012
,2003, 'Prognostic significance of Gleason pattern in patients with Gleason score 7 prostate carcinoma', Cancer, 98, pp. 2560 - 2565
,